Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mona Fiuzat

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Archives of Internal Medicine|December 17, 2009
Antidepressant Use, Depression, and Poor Cardiovascular Outcomes: The Chicken or the Egg?: Comment on "Antidepressant Use and Risk of Incident Cardiovascular Morbidity and Mortality Among Postmenopausal Women in the Women's Health Initiative Study"Christopher O'Connor, Mona Fiuzat
Heart Failure Clinics|September 20, 2011
Lessons learned from clinical trials in acute heart failure: phase 3 drug trialsChristopher M O'Connor, Mona Fiuzat
Heart Failure Clinics|March 25, 2014
Sleep-disordered breathing in patients with heart failureRobert J Mentz, Mona Fiuzat
Circulation. Heart Failure|May 14, 2024
How Did We Score? Evaluating the Utility of a Score-Based System for Heart Failure Medical TherapyAnkeet S Bhatt, Mona Fiuzat
JAMA Cardiology|September 1, 2016
The US Food and Drug Administration and the Future of Cardiovascular MedicineMona Fiuzat, Robert M Califf
Heart Failure Clinics|September 20, 2011
Clinical trials in acute decompensated heart failure--over 50 years of researchChristopher M O'Connor, Mona Fiuzat
Heart Failure Clinics|September 20, 2011
Conduct of clinical trials in acute heart failure: regional differences in heart failure clinical trialsMona Fiuzat, Robert M Califf
Heart Failure Clinics|September 20, 2011
Pharmacogenetics in heart failure trialsMona Fiuzat, Michael R Bristow
JACC. Heart Failure|December 3, 2014
Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodelingMona Fiuzat, John C Burnett
JACC. Heart Failure|December 14, 2020
Putting the "Optimal" in Optimal Medical TherapyErsilia M DeFilippis, Mona Fiuzat
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Archives of Internal Medicine|December 17, 2009
Antidepressant Use, Depression, and Poor Cardiovascular Outcomes: The Chicken or the Egg?: Comment on "Antidepressant Use and Risk of Incident Cardiovascular Morbidity and Mortality Among Postmenopausal Women in the Women's Health Initiative Study"Christopher O'Connor, Mona Fiuzat
Heart Failure Clinics|September 20, 2011
Lessons learned from clinical trials in acute heart failure: phase 3 drug trialsChristopher M O'Connor, Mona Fiuzat
Heart Failure Clinics|March 25, 2014
Sleep-disordered breathing in patients with heart failureRobert J Mentz, Mona Fiuzat
Circulation. Heart Failure|May 14, 2024
How Did We Score? Evaluating the Utility of a Score-Based System for Heart Failure Medical TherapyAnkeet S Bhatt, Mona Fiuzat
JAMA Cardiology|September 1, 2016
The US Food and Drug Administration and the Future of Cardiovascular MedicineMona Fiuzat, Robert M Califf
Heart Failure Clinics|September 20, 2011
Clinical trials in acute decompensated heart failure--over 50 years of researchChristopher M O'Connor, Mona Fiuzat
Heart Failure Clinics|September 20, 2011
Conduct of clinical trials in acute heart failure: regional differences in heart failure clinical trialsMona Fiuzat, Robert M Califf
Heart Failure Clinics|September 20, 2011
Pharmacogenetics in heart failure trialsMona Fiuzat, Michael R Bristow
JACC. Heart Failure|December 3, 2014
Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodelingMona Fiuzat, John C Burnett
JACC. Heart Failure|December 14, 2020
Putting the "Optimal" in Optimal Medical TherapyErsilia M DeFilippis, Mona Fiuzat
Pageof 22